Fever in the neutropenic host.
Fever in the neutropenic patient following myelosuppressive chemotherapy is a medical emergency. Appropriate antimicrobial therapy can dramatically reduce infection-related morbidity and mortality. This article reviews the rationale and methodology of treatment as well as its applicability to other neutropenic states. The utility of adjunct therapy with granulocyte- stimulating compounds is also discussed.
Chanock
S J
SJ
Infectious Disease Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Pizzo
P A
PA
D004630:Emergencies; D005334:Fever; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects; D009503:Neutropenia / Q000150:complications* / Q000209:etiology*
D007166:Immunosuppressive Agents